δ-related Biomarkers Attenuate Multiple AD Conversion Risks and Offer Targets for Intervention.
We tested certain serum proteins' ability to mediate the effects of demographic variables on prospective 5yr conversion to clinical "Alzheimer's Disease" (AD) from non-demented states [i.e., Normal Control (NC) and Mild Cognitive Impairment (MCI)]. The proteins were rationally selected from among previously published mediators of those same variables' associations with the latent variable "δ", a novel omnibus dementia severity metric. Each protein's attenuation of its risk factor's independent association with conversion was confirmed by logistic regression, adjusted for education, ethnicity, self-reported diabetes mellitus and hypertension, among N = 772 initially non-demented Mexican-American (MA) and non-Hispanic White (NHW) participants in the Texas Alzheimer`s Research and Care Consortium (TARCC). n = 70 non-demented participants at baseline converted to "AD" (9.1%) after a mean follow-up of 5.4 yrs. Age >80yrs (OR = 3.1), Geriatric Depression Scale (GDS30) > 10/30 (OR = 2.3), female gender (OR = 2.2) and the presence of an apolipoprotein E (APOE) ε4 allele (OR = 2.4) were independently associated with prospective conversion. These effects were fully attenuated by five serum proteins: AGE: Insulin-like Growth Factor-Binding Protein 2 (IGF-BP2), Epidermal Growth Factor Receptor 1 (EGFR); Depression: Resistin; Gender: Thrombopoeitin (THPO); APOE: C-Reactive Protein (CRP). Clinical dementia arises from the sum of independent δ-related processes. This analysis provides proof of concept for the rational selection of anti-dementia targets and offers a foundation for precision anti-dementia therapy.